Emma Walmsley’s praise for US pharmaceutical market piles pressure on UK government ...
HSBC analyst Rajesh Kumar raised the firm’s price target on GSK (GSK) to 1,500 GBp from 1,200 GBp and keeps a Reduce rating on the shares as part ...
Dame Emma Walmsley, Chief Executive one of Britain's biggest pharmaceutical companies GSK (GlaxoSmithKline), says the company is prioritising the United States for product launches and investment, ...
While successive governments have stressed that the UK is a superpower in life sciences, in the eyes of one of the country's ...
GSK (LSE:GSK) has delivered share price gains of 9% over the past month and 16% in the past 3 months, reflecting steady investor interest. This performance comes as the pharmaceutical sector continues ...